Seminars in Oncology

Papers
(The H4-Index of Seminars in Oncology is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Unlocking the therapeutic potential of polyphenols: Promising advances and future directions in pancreatic cancer treatment40
Integrated analysis of scRNA-seq and bulk RNA-seq data identifies BHLHE40 as a key gene in pancreatic cancer progression and gemcitabine resistance38
Hepatitis B Virus Reactivation in Cancer Patients Receiving Chemotherapy—A Systematic Review and Meta-Analysis27
Airway disorders associated with immune checkpoint inhibitor therapy: Two case reports and a systematic review24
Breaking barriers: Deciphering the mechanisms of Olaparib resistance in prostate cancer21
Editorial Board18
Military exposures and lung cancer in United States Veterans16
Deciphering the US Regulatory Framework: Comparison Between Oncology Biosimilars and Reference Biologics16
Global distribution of prophylactic total gastrectomy in E-cadherin (CDH1) mutations15
Table of Contents14
Explainable machine learning and feature interpretation to predict survival outcomes in the treatment of lung cancer13
Editorial Board12
Influence of Cancer on COVID-19 Incidence, Outcomes, and Vaccine Effectiveness: A Prospective Cohort Study of U.S. Veterans12
Role of neoadjuvant pembrolizumab in advanced melanoma12
0.041680097579956